GRAIL, Inc. is a services-medical laboratories company trading on XNAS, led by CEO Robert Ragusa, with a market cap of $2.0B.
Upcoming earnings announcement for GRAIL, Inc.
Past 7 earnings reports for GRAIL, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 19, 2026 | Q4 2025 | -$2.44Est: -$2.93 | +16.7% | $43.6MEst: $43.5M | +0.3% | |
| Nov 12, 2025 | Q3 2025 | -$2.46Est: -$3.36 | +26.8% | $36.2MEst: $34.7M | +4.3% | |
| Aug 12, 2025 | Q2 2025 | -$3.18Est: -$3.39 | +6.2% | $35.5MEst: $36.4M | -2.5% | |
| May 13, 2025 | Q1 2025 | -$3.10Est: -$3.80 | +18.4% | $31.8MEst: $35.2M | -9.6% | |
| Feb 20, 2025 | Q4 2024 | -$2.89 | — | $38.3M | — | |
| Nov 12, 2024 | Q3 2024 | -$3.94 | — | $28.7M | — | |
| Aug 13, 2024 | Q2 2024 | -$5.30 | — | $32.0M | — |
We use cookies for analytics. See our Privacy and Cookie Policy.